Puma Biotechnology (PBYI) EBT Margin (2017 - 2026)
Puma Biotechnology (PBYI) posted EBT Margin of 7.65% for Q1 2026, down 133.73% on a QoQ basis from 22.67% in Q4 2025, and down 1475.0% year-over-year from 0.56% in Q1 2025.
Puma Biotechnology (PBYI) EBT Margin (2017 - 2026) Analysis & Trends
Puma Biotechnology's EBT Margin history runs 10 years deep, the most recent figure standing at 7.65% for Q1 2026.
- Quarterly EBT Margin fell 1475.0% year-over-year to 7.65% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 12.8% (up 943.0% YoY) and the FY2025 annual result came in at 15.67%, changed N/A from the prior year.
- EBT Margin was 7.65% for Q1 2026 at Puma Biotechnology, down from 22.67% in the prior quarter.
- Across five years, EBT Margin topped out at 25.59% in Q3 2024 and bottomed at 20.08% in Q4 2024.
- A 5-year average of 4.39% and a median of 4.24% in 2023 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin soared 9601 bps — and 2024, when it tumbled 3782 bps.
- Puma Biotechnology's EBT Margin stood at 6.06% in 2022, then jumped by 393 bps to 17.74% in 2023, then plunged by 213 bps to 20.08% in 2024, then surged by 213 bps to 22.67% in 2025, then slumped by 134 bps to 7.65% in 2026.
- Business Quant data shows PBYI's EBT Margin at 7.65% in Q1 2026, 22.67% in Q4 2025, and 16.97% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Puma Biotechnology | 407.27 Mn | 368.99 Mn | 34.39 Mn | -7.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.65% |
| Dec 31, 2025 | 22.67% |
| Sep 30, 2025 | 16.97% |
| Jun 30, 2025 | 11.76% |
| Mar 31, 2025 | 7.10% |
| Dec 31, 2024 | -20.08% |
| Sep 30, 2024 | 25.59% |
| Jun 30, 2024 | -8.82% |
| Mar 31, 2024 | -10.50% |
| Dec 31, 2023 | 17.74% |
| Sep 30, 2023 | 10.71% |
| Jun 30, 2023 | 4.24% |
| Mar 31, 2023 | 2.93% |
| Dec 31, 2022 | -6.06% |
| Sep 30, 2022 | -0.51% |
| Jun 30, 2022 | 15.84% |
| Mar 31, 2022 | -7.36% |
| Dec 31, 2021 | 8.01% |
| Sep 30, 2021 | -96.52% |
| Jun 30, 2021 | -9.49% |